share_log

Jolt Health Inc. Announces Closing of Financing

Jolt Health Inc. Announces Closing of Financing

Jolt Health Inc. 宣佈完成融資
Accesswire ·  03/28 04:50

VANCOUVER, BC / ACCESSWIRE / March 27, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announces it has closed its previously announced non-brokered private placement. The Company accepted subscriptions for 50,000,000 units at a price of $0.01 per unit (the "Units") for gross proceeds of $500,000 (the "Financing").

不列顛哥倫比亞省溫哥華/ACCESSWIRE /2024年3月27日/Jolt Health Inc.(“JOLT” 和/或 “公司”)(CSE: JOLT)(FSE: G1Q0)宣佈已完成先前宣佈的非經紀私募配售。該公司接受了以每單位0.01美元(“單位”)的價格訂閱5000萬個單位,總收益爲50萬美元(“融資”)。

One insider of the Company subscribed for an aggregate of 1,500,000 units of the Company. The Company has relied on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(a) of MI 61-101 in respect of such insider participation.

該公司的一位內部人士認購了該公司共計150萬個單位。對於此類內幕人士的參與,該公司依賴密歇根州61-101號文件第5.5(b)和5.7(a)節中MI 61-101的估值和少數股東批准要求的豁免。

Pursuant to the terms of the Financing, each Unit consists of one common share in the equity of the Company and one half common share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase one additional common share of the Company at a price of $0.05 per share for a period of two (2) years from the closing of the Financing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days.

根據融資條款,每個單位由公司股權中的一股普通股和一半的普通股購買權證(“認股權證”)組成。每份認股權證使持有人有權在融資結束後的兩(2)年內以每股0.05美元的價格額外購買公司的一股普通股,但如果其股票連續10天交易價格爲0.15美元或以上,公司可以選擇加快到期日。

Securities issued are subject to trading restrictions until July 28, 2024.

在2024年7月28日之前,發行的證券將受到交易限制。

Proceeds will be used for general working capital and repayment of debt, except accrued salaries to officers or directors or payment for investor relations.

所得款項將用於一般營運資金和償還債務,但高管或董事的應計工資或投資者關係付款除外。

About Jolt Health Inc.
Jolt Health Inc. (CSE:JOLT) is a leading life sciences company focused on healthcare, biotechnology and artificial intelligence. The company currently holds exclusive licenses for innovative therapeutic and pharmaceutical products throughout Europe, the UK, and North America. The company is committed to transforming the industry through research, collaboration, and technological advancement, shaping the future of healthcare worldwide.

關於 Jolt Health Inc.
Jolt Health Inc.(CSE: JOLT)是一家領先的生命科學公司,專注於醫療保健、生物技術和人工智能。該公司目前在歐洲、英國和北美擁有創新治療和藥品的獨家許可。該公司致力於通過研究、合作和技術進步實現行業轉型,塑造全球醫療保健的未來。

For further information, please contact:
Investor Relations
Telephone: 1 (604) 343-2977
E-mail: info@jolt-health.com

欲了解更多信息,請聯繫:
投資者關係
電話:1 (604) 343-2977
電子郵件:info@jolt-health.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其監管服務提供商(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward-Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may" or "believes" or "variations" (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, risks relating to epidemics or pandemics such as COVID-19, including the impact of COVID-19 on the Company's business, financial condition and results of operations, lack of investor demand for Bitcoin and/or Bitcoin futures exchange traded funds, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

前瞻性陳述
本新聞稿中列出的某些信息可能包含前瞻性陳述,涉及大量已知和未知的風險和不確定性。除歷史事實陳述以外的所有陳述均爲前瞻性陳述,包括但不限於有關公司未來財務狀況、業務戰略、所得款項用途、企業願景、擬議收購、夥伴關係、合資企業和戰略聯盟以及合作、預算、成本和計劃及目標的陳述。此類前瞻性信息反映了管理層當前的信念,並基於管理層目前可獲得的信息。通常,但並非總是如此,前瞻性陳述可以通過使用諸如 “計劃”、“期望”、“預期”、“預算”、“預期”、“估計”、“預測”、“打算”、“目標”、“目標”、“預期”、“可能” 或 “相信” 或 “變體”(包括負面變體)等詞語來識別,也可以通過陳述來識別其大意是 “可能”、“可以”、“應該”、“將”、“可能” 或 “將” 採取、發生或實現某些行動。許多已知和未知的風險、不確定性和其他因素可能導致實際業績或業績與前瞻性信息所表達或暗示的任何未來業績或業績存在重大差異。這些前瞻性陳述受到許多風險和不確定性的影響,其中某些風險和不確定性是公司無法控制的,包括但不限於總體經濟狀況、行業狀況、與 COVID-19 等流行病相關的風險,包括 COVID-19 對公司業務、財務狀況和經營業績的影響、投資者對比特幣和/或比特幣期貨交易所交易基金的需求不足以及對監管部門批准的依賴。請讀者注意,在準備此類信息時使用的假設雖然在準備時被認爲是合理的,但可能被證明是不準確的,因此,不應過度依賴前瞻性陳述。除非證券法要求,否則公司不承擔任何更新或修改其前瞻性陳述的義務,無論是由於新信息、未來事件還是其他原因。

SOURCE: Jolt Health Inc.

資料來源:Jolt Health Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論